8^th World Congress and Exhibition on Antibiotics and Antibiotic Resistance March 08-09, 2021 Rome, Italy

Sanjib Bhakta is currently a full-Professor of Molecular Microbiology and Biochemistry, Strategic Dean (Internationalisation and Partnership) and Programme Director of MRes Global Infectious Diseases at the Institute of Structural and Molecular Biology, Birkbeck, University of London and UCL. Following a BSc (Hons), an MSc and a PhD in Molecular Microbiology & Biochemistry from world class Universities & Research Institutions in India, Dr Bhakta joined the Oxford University Division of Medical Sciences as an Oxford University innovation Senior Research Scholar and shortly after he was awarded with a Wellcome Trust International post-doctoral Fellowship. He graduated from The Queen’s College, University of Oxford completing a second doctoral degree (DPhil in Pharmacology) and received a “Sir William Paton Prize” from the Oxford University Division of Medicine. He is an “Antibiotic Action Champion” member of the British Society for Antimicrobial Chemotherapy.

Tackling antimicrobial resistance in global infectious bacterial pathogens including Mycobacterium tuberculosis. His graduate research was on the structural and functional characterisation of β-lactam drug targets. He has also investigated a number of endogenous pathways and molecular machines (cell-wall and cell-division associated proteins) and the role of transporter proteins in relation to efflux-mediated antimicrobial resistance.

Surbhi Malhotra-Kumar is a clinical and molecular microbiologist, actively involved in the development of high-throughput and POC diagnostic assays for hospital and community pathogens. Using state-of-the-art molecular techniques, she is studying the impact of antibiotic use at the individual level and the role of virulence factors in biofilm formation as well as utilising metagenomics to study bacterial pathogenetic mechanisms and antibiotic resistance.

Antibiotic resistance

Mainul Haque is currently Professor of the Unit of Pharmacology, Faculty of Medicine and Defence Health, National Defence University of Malaysia, Kuala Lumpur, MALAYSIA. He has continuously published several articles in index journals. These works are published in many PubMed, SCOPUS, and ISI index journals. My 05 article of 2013 and 2014 has been identified as high quality by UniSZA authority and awarded. He was the Head of the Department of Pharmacology, Ibrahim Medical College, (An Institution of the Diabetic Association of Bangladesh), Bangladesh. Dr. Mainul obtained MBBS, MPhil (Medical Pharmacology), MSc (International Health), CIDTT (Teaching and Learning), FPCP (Glasgow) world-class Universities & Research Institutions in Bangladesh, and the UK" with " Dr. Mainul obtained MBBS, MPhil (Medical Pharmacology), MSc (International Health), CIDTT (Teaching and Learning), FPCP (Glasgow) from world-class Universities & Research Institutions in Bangladesh, and the UK. He had published totally 270 articles, Number of Articles in SCOPUS: 167.

Pharmacology & Therapeutics, Drug Utilization, Antibiotic Resistance, Rational Use of Medicine, Prudent Utilization of Antimicrobials, Public Health, Community Medicine, Medical Education, Medical Professionalism, Medical Empathy.

Masoud H Manjili is an Associate Professor of Immunology at the Department of Microbiology Immunology Virginia Commonwealth University School of Medicine and Member of Massey Cancer Center Richmond VA. He conducted his postdoctoral fellowship at Roswell Park Cancer Institute Buffalo NY 1999-2003. He has received a PhD in Immunology from The University of Sydney Australia 1993-1996. He has received a DVM from The University of Tehran Iran 1983-1990. He is serving as a Managing Editor of Frontiers in Bioscience.

Immunotherapy of tumor dormancy, Re-programming tumor-immune crosstalk to overcome tumor escape, Prognostic biomarkers for cancer, The adaptation model of immunity

Professor Timms is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections

His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity.